COLORADO – August 2025 – August 1 marks World Lung Cancer Day, a global observance dedicated to raising awareness about lung cancer, encouraging early detection and supporting the individuals and families affected by this disease. At Rocky Mountain Cancer Centers (RMCC), we are committed in solidarity with patients, survivors, and caregivers as we work every day to advance the fight against lung cancer.

Lung cancer remains one of the leading causes of cancer-related deaths worldwide, impacting both smokers and non-smokers. The often-silent onset means many cases are diagnosed at later stages, when treatment options may be more limited. World Lung Cancer Day is a powerful reminder of the importance of understanding risk factors, recognizing potential symptoms and seeking screening and care early.

“Raising awareness about lung cancer can and does save lives,” said Manojkumar Bupathi, MD, MS, president and medical oncologist at RMCC. “The sooner lung cancer is detected, the greater the chances are for effective treatment and long-term survival. That’s why this day matters—it brings critical attention to a disease that too often hides in plain sight.”

At RMCC, we are proud to offer state-of-the-art lung cancer care across Colorado. Our team includes oncologists who specialize specifically in thoracic (lung) cancers, ensuring patients benefit from in-depth expertise, leading-edge therapies, and personalized treatment plans that address both the medical and emotional aspects of care.

“Lung cancer is not a one-size-fits-all disease,” said Eiko Browning, MD, medical oncologist and hematologist at RMCC. “It can affect anyone, regardless of smoking history. We now have incredibly advanced tools—from molecular testing to immunotherapies—that allow us to tailor treatments in powerful new ways. All those advances are most powerful when people are diagnosed early.”

RMCC is committed to helping Coloradans understand their lung cancer risk, access appropriate screenings, and receive the best possible care. On this World Lung Cancer Day, we join healthcare providers and advocates around the world in urging individuals to learn the signs, talk to their doctors, and support loved ones navigating a lung cancer diagnosis.

For more information, please visit rockymountaincancercenters.com/lung-cancer or contact your nearest RMCC location.

RMCC is part of The U.S. Oncology Network, a highly respected national organization collaborating to advance innovative care and deliver optimal outcomes. As Colorado’s leader in cancer treatment, we’ve been delivering world-class cancer care with compassion and expertise for more than 30 years, and we make our patients’ lives easier by offering coordinated care access in 19 locations throughout Colorado. So, if you find yourself facing new challenges in your health journey, we’ll be on your side, empowering Your Courage with Our Proven Experience.

# # #

Rocky Mountain Cancer Centers (RMCC) is an independent, physician-led practice that delivers leading-edge technology and treatment options and conducts innovative research. For more than 30 years, RMCC has pioneered community-based care to enable more cancer patients to receive high-quality treatment while staying close to the support of family and friends.

Rocky Mountain Cancer Centers treats more adult cancer than any other healthcare organization in Colorado, providing 19 locations and a network of 54 physicians specializing in cancer care throughout the state. RMCC is collectively focused on treating cancer and blood disorders with advanced technology and innovative research no matter where you live, while taking a community-based approach of integrated subspecialty oncology care. This enables patients to access leading-edge treatment while living at home and receiving the critical support of family and friends.

Patients who are treated at RMCC can participate in some of the most promising national clinical trials for a broad range of cancers. RMCC has played a role in the development of more than 100 FDA-approved cancer-fighting drugs – about one-third of cancer therapies approved by the FDA to date. At any given time, more than 150 national clinical trials are open throughout The Network.

Media Contacts
RMCC Media
RMCCmedia@usoncology.com